MedTrace Logo

Effectiveness of Passive and Active ROM Exercises Following TKA

NCT02062138 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-05-22

No results posted yet for this study

Summary

The purpose of the study is to determine the effectiveness of new interventional approaches in the early postoperative phase following total knee arthroplasty (TKA). It is assumed that active training programs are more effective in improving physical function than the passive standard-of-care therapy.

Conditions

Interventions

OTHER

continuous passive motion (CPM)

standard-of-care therapy (control intervention); Patients receive three 30 minutes CPM applications (unilateral op-leg) each day from the second postoperative day until 1 day prior to discharge.

OTHER

controlled active motion (CAM I)

Patients receive three 30 minutes CAM applications (unilateral op-leg) each day from the second postoperative day until 1 day prior to discharge.

OTHER

controlled active motion (CAM II)

Patients receive three 30 minutes CAM applications (bilateral alternating) each day from the second postoperative day until 1 day prior to discharge.

Sponsors & Collaborators

  • University of Rostock

    lead OTHER

Principal Investigators

  • Rainer Bader, MD · Department of Orthopedics, University Medicine Rostock

  • Ralf Skripitz, MD · Department of Orthopedics, University Medicine Rostock

  • Anett Mau-Moeller, M.A. · Department of Orthopedics, University Medicine Rostock

  • Martin Behrens · Department of Kinesiology, University of Rostock

  • Tino Stöckel, PhD · Department of Kinesiology, University of Rostock

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-01-31
Completion
2016-04-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02062138 on ClinicalTrials.gov